Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

2,312 results

  1. ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based ...
  2. ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based ...
  3. ... PubMed : 7514435 ] Greco FA, Vaughn WK, Hainsworth JD: Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. Ann Intern ...
  4. ... of care in a trial of chemotherapy for advanced non-small cell lung cancer. Lung Cancer (01695002). 2002; 37 (2):219. [ PubMed : 12140146 ] Briasoulis E, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. ...
  5. ... with 5-fluorouracil and cisplatin in patients with advanced cancer. Cancer Chemotherapy ... of unknown primary site. Journal of Clinical Oncology. 1995; 13 (7): ...
  6. ... II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine ... Cancer investigation. 1995; 13 (3):263–6. [ PubMed : ...
  7. ... ToolKit ToolKitAll ToolKitBookgh Search term Search Browse ... of Unknown Primary Treatment (PDQ®) Patient Version PDQ Adult Treatment Editorial ...
  8. ... ToolKit ToolKitAll ToolKitBookgh Search term Search Browse ... Carcinoma of Unknown Primary Treatment (PDQ®) Patient Version PDQ Pediatric Treatment Editorial ...
  9. ... V, Buckstegge B, Bocking A. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagnostic Cytopathology. 2005; 33 (5):309–15. [ PubMed : 16240395 ] Schwartz PE, Zheng W. Neoadjuvant chemotherapy for advanced ovarian cancer: the role of cytology in pretreatment ...
  10. ... or neo-adjuvant chemotherapy for people with locally-advanced (stage II and above) ... Unknown primary of presumed upper aerodigestive tract origin 1.7. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last